株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

次世代シークエンシング (NGS) の世界市場予測 2021年:ターゲットシークエンシング・De Novoシークエンシング・全ゲノムシークエンシング・メチル化シークエンシング

Next-Generation Sequencing (NGS) Market by Platforms (HiSeq, MiSeq, HiSeq X Ten/X Five, Nextseq500, Ion Proton, PGM, IonS5, PacBio & Sequel), Services (Targeted Sequencing, De novo), & Application (Diagnostic, Drug Discovery) - Global Forecasts to 2021

発行 MarketsandMarkets 商品コード 235782
出版日 ページ情報 英文 209 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.71円で換算しております。
Back to Top
次世代シークエンシング (NGS) の世界市場予測 2021年:ターゲットシークエンシング・De Novoシークエンシング・全ゲノムシークエンシング・メチル化シークエンシング Next-Generation Sequencing (NGS) Market by Platforms (HiSeq, MiSeq, HiSeq X Ten/X Five, Nextseq500, Ion Proton, PGM, IonS5, PacBio & Sequel), Services (Targeted Sequencing, De novo), & Application (Diagnostic, Drug Discovery) - Global Forecasts to 2021
出版日: 2016年03月09日 ページ情報: 英文 209 Pages
概要

世界の次世代シークエンシング (NGS) 市場は、2016年から2021年にかけて20.8%のCAGRで推移し、2016年の40億3,170万米ドルから、2021年までに103億7,110万米ドルへ達すると予測されています。北米は2016年における世界のNGS市場において最大のシェアを構成すると予測されています。

当レポートでは、次世代シークエンシング (NGS) の世界市場に注目し、世界的成長を展望しながら、製品・サービス、アプリケーション、および地域別に同市場の現況と予測数値をまとめるほか、製品開発動向や競合環境、主要企業などについての最新情報を提供しています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 世界のNGS市場
  • 世界のNGS市場シェア:製品・サービス別
  • NGSシークエンシングサービス市場:アプリケーション別
  • 世界のNGS技術市場規模:地域別

第5章 市場概要

  • イントロダクション
  • 市場区分
    • 製品 & サービス別
    • 技術別
    • アプリケーション別
    • エンドユーザー別
  • 市場ダイナミクス
    • 推進要因
    • 抑制要因
    • 機会
    • 課題
    • 現在の市場動向

第6章 世界のNGS市場:製品・サービス別

  • イントロダクション
  • プレシークエンシング製品・サービス
    • サンプル調製
  • NGSプラットフォーム・消耗品・プラットフォーム向けサービス
    • NGSプラットフォーム市場
  • シークエンシングサービス
    • ターゲットリシークエンシング
    • RNAシークエンシング
    • De Novoシークエンシング
    • エクソームシークエンシング
    • チップシークエンシング
    • 全ゲノムシークエンシング
    • メチル化シークエンシング
    • その他
  • NGSデータ分析・ストレージ・管理 (バイオインフォマティクス)

第7章 世界のNGS市場:技術別

  • イントロダクション
  • 合成法シークエンシング (SBS)
  • イオン半導体シークエンシング
  • ライゲーション法シークエンシング (SBL)
  • パイロシークエンシング
  • 一分子リアルタイムシークエンシング (SMART)
  • その他の技術

第8章 世界のNGS市場:アプリケーション別

  • イントロダクション
  • 診断
  • 創薬
  • バイオマーカー探索
  • 個別化医療
  • 農業 & 動物研究
  • その他のアプリケーション

第9章 NGS市場:エンドユーザー別

  • イントロダクション
    • 研究センターおよび学問&政府機関
    • 病院 & クリニック
    • 医薬品 & バイオテクノロジー企業
    • その他のエンドユーザー (NPO・アグリゲノミクス組織・個人消費者向けゲノム企業)

第10章 次世代シークエンシング市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域 (ROW)

第11章 競合環境

  • 概要
  • 市場シェア分析
  • 競合状況・動向

第12章 企業プロファイル

  • イントロダクション
  • ILLUMINA, INC.
  • THERMO FISHER SCIENTIFIC, INC.
  • PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
  • BEIJING GENOMICS INSTITUTE
  • QIAGEN N.V.
  • 454 LIFE SCIENCES CORPORATION (ROCHE HOLDING AG)
  • AGILENT TECHNOLOGIES, INC.
  • EUROFINS SCIENTIFIC
  • GATC BIOTECH AG
  • MACROGEN INC.
  • OXFORD NANOPORE TECHNOLOGIES, LTD.
  • PERKINELMER, INC.

第13章 付録

図表リスト

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: BT 2697

The global NGS market is expected to reach USD 10,371.1 million by 2021 from USD 4,031.7 million in 2016, at a CAGR of 20.8% between 2016 and 2021. North America is expected to hold the largest share of the global NGS market in 2016. The NGS market is broadly segmented into products & services, technology, application, and end user. By products & services, the NGS market is segmented into pre-sequencing products & services, NGS platforms, consumables, sequencing services, data analysis/bioinformatics. The consumables segment is expected to command the major share of the NGS market, by products& services, in 2016.

Geographically, the report covers four major geographies, namely, North America, Europe, Asia-Pacific, and the Rest of the World. North America is expected to command the largest share of the global NGS market in 2016, followed by Europe. Asia-Pacific NGS market is poised to witness highest growth rate during the forecast period from 2016 to 2021 due to a number of factors including improving healthcare infrastructure and favorable government initiatives.

Market growth is majorly driven by the technological advancements in NGS products, increasing applications of NGS, entry of new market players, increasing partnerships & collaborations among market players, and growing incidences of cancer, inherited rare disorders, and pre- and neo-natal disorders.

As of 2015, the global NGS market was dominated by Illumina, Inc. (U.S.); Thermo Fisher Scientific, Inc. (U.S.); and Pacific Biosciences of California, Inc. (U.S.) which together held a share of 94% of the overall NGS platforms market. New product launches & product enhancements; agreements, collaborations, & partnerships, geographic expansions; strategic acquisitions; and others (offering research fund & grants and organizing conferences/seminars) are the major strategies adopted by most market players to achieve growth in the global NGS market.

Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis -market share analysis of top players, and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging and high-growth segments of the NGS market, high-growth regions and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, and competitive assessment) for strengthening their market share.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on NGS products offered by the top 10 players in the NGS market. The report analyzes the NGS market by products & services, technology, application, and end user
  • Product Development/Innovation: Detailed insights on current and upcoming technologies, research and development activities, product enhancements, and new product launches in the NGS market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various NGS devices across four geographies
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the NGS market

Table of Contents

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Breakdown of primaries
      • 2.1.2.2. Key data from primary sources
      • 2.1.2.3. Key industry insights
  • 2.2. MARKET SIZE ESTIMATION
    • 2.2.1. BOTTOM-UP APPROACH
    • 2.2.2. TOP-DOWN APPROACH
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. RESEARCH ASSUMPTIONS

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION
  • 3.2. CURRENT SCENARIO
  • 3.3. FUTURE OUTLOOK
  • 3.4. CONCLUSION

4. PREMIUM INSIGHTS

  • 4.1. GLOBAL NGS MARKET (2016-2021)
  • 4.2. GLOBAL NGS MARKET SHARE, BY PRODUCTS & SERVICES (2016 VS. 2021)
  • 4.3. NGS SEQUENCING SERVICES MARKET, BY APPLICATIONS (2016 VS. 2021)
  • 4.4. GLOBAL NGS TECHNOLOGY MARKET SIZE, BY REGION (2016-2021)

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET SEGMENTATION
    • 5.2.1. BY PRODUCTS & SERVICES
    • 5.2.2. BY TECHNOLOGY
    • 5.2.3. BY APPLICATION
    • 5.2.4. BY END USER
  • 5.3. MARKET DYNAMICS
    • 5.3.1. DRIVERS
      • 5.3.1.1. Technological Advancements in Sequencing Platforms
      • 5.3.1.2. Increasing Applications of NGS
      • 5.3.1.3. Growing Partnerships and Collaborations
      • 5.3.1.4. Research Laboratories and Academicians Promoting NGS
      • 5.3.1.5. Entry of New Market Players
      • 5.3.1.6. Conferences and Workshops Increasing Awareness on NGS Products and Services
    • 5.3.2. RESTRAINTS
      • 5.3.2.1. Accuracy & Standardization Concerns in Diagnostic Testing
      • 5.3.2.2. Lack of Skilled Professionals
      • 5.3.2.3. Ethical and Legal Issues Related to NGS
    • 5.3.3. OPPORTUNITIES
      • 5.3.3.1. Personalized Medicine & Biomarker Discovery Open Avenues for the Growth of NGS Market
      • 5.3.3.2. Emerging Markets Offer Numerous Growth Opportunities
      • 5.3.3.3. Cloud Computing, a Prospective Service
    • 5.3.4. CHALLENGES
      • 5.3.4.1. Interpretation of Complex Data from NGS Platforms
      • 5.3.4.2. Storage of Sequencing Data
    • 5.3.5. CURRENT TRENDS
      • 5.3.5.1. Development of New and Advanced NGS Platforms
      • 5.3.5.2. Focus on Cancer Research
      • 5.3.5.3. Mergers and Acquisitions

6. GLOBAL NGS MARKET, BY PRODUCTS & SERVICES

  • 6.1. INTRODUCTION
  • 6.2. PRE-SEQUENCING PRODUCTS & SERVICES
    • 6.2.1. SAMPLE PREPARATION
      • 6.2.1.1. DNA Fragmentation, End Repair, A-tailing, and Size Selection
      • 6.2.1.2. Library Preparation & Target Enrichment
      • 6.2.1.3. Quality Control
  • 6.3. NGS PLATFORMS, CONSUMABLES, & SERVICES FOR PLATFORMS
    • 6.3.1. NGS PLATFORMS MARKET
      • 6.3.1.1. Illumina
        • 6.3.1.1.1. HiSeq Series
        • 6.3.1.1.2. HiSeq X Ten & HiSeq X Five
        • 6.3.1.1.3. MiSeq Series
        • 6.3.1.1.4. NextSeq500
      • 6.3.1.2. Thermo Fisher Scientific (Life Technologies)
        • 6.3.1.2.1. SOLiD Series
        • 6.3.1.2.2. Ion Torrent Platforms
        • 6.3.1.2.2.1. Ion PGM
        • 6.3.1.2.2.2. Ion Proton
        • 6.3.1.2.2.3. Ion S5 & S5 XL
      • 6.3.1.3. Pacific Biosciences
        • 6.3.1.3.1. PacBio RS II
        • 6.3.1.3.2. Sequel System
      • 6.3.1.4. Recently Launched Sequencing Platforms
  • 6.4. SEQUENCING SERVICES
    • 6.4.1. TARGETED RE-SEQUENCING
    • 6.4.2. RNA-SEQ
    • 6.4.3. DE NOVO SEQUENCING
    • 6.4.4. EXOME SEQUENCING
    • 6.4.5. CHIP-SEQ
    • 6.4.6. WHOLE-GENOME SEQUENCING
    • 6.4.7. METHYL-SEQ
    • 6.4.8. OTHERS
  • 6.5. NGS DATA ANALYSIS, STORAGE, AND MANAGEMENT (BIOINFORMATICS)
      • 6.5.1.1. NGS Data Analysis Software & Workbenches
      • 6.5.1.2. NGS Data Analysis Services
      • 6.5.1.3. NGS Storage, Management, and Cloud Computing Solutions

7. GLOBAL NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY

  • 7.1. INTRODUCTION
  • 7.2. SEQUENCING BY SYNTHESIS (SBS)
  • 7.3. ION SEMICONDUCTOR SEQUENCING
  • 7.4. SEQUENCING BY LIGATION (SBL)
  • 7.5. PYROSEQUENCING
  • 7.6. SINGLE-MOLECULE REAL-TIME SEQUENCING (SMRT)
  • 7.7. OTHER TECHNOLOGIES

8. GLOBAL NGS MARKET, BY APPLICATION

  • 8.1. INTRODUCTION
  • 8.2. DIAGNOSTICS
  • 8.3. DRUG DISCOVERY
  • 8.4. BIOMARKER DISCOVERY
  • 8.5. PERSONALIZED MEDICINE
  • 8.6. AGRICULTURE & ANIMAL RESEARCH
  • 8.7. OTHER APPLICATIONS

9. NEXT-GENERATION SEQUENCING MARKET, BY END USER

  • 9.1. INTRODUCTION
    • 9.1.1. RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES
    • 9.1.2. HOSPITALS & CLINICS
    • 9.1.3. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 9.1.4. OTHER END-USERS (NPO, AGRIGENOMICS ORGANIZATIONS, CONSUMER GENOMIC COMPANIES)

10. NEXT GENERATION SEQUENCING MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. U.S.
      • 10.2.1.1. Favorable government funding scenario in the U.S. market
      • 10.2.1.2. Growing focus of NGS market players on strengthening their presence in the U.S.
      • 10.2.1.3. Increasing number of NGS conferences in the U.S.
      • 10.2.1.4. Increasing focus of laboratories to obtain CLIA certification
    • 10.2.2. CANADA
      • 10.2.2.1. Favorable government funding scenario in Canada
      • 10.2.2.2. Growing focus of market players on expanding their presence in Canada
  • 10.3. EUROPE
    • 10.3.1. MARKET PLAYERS CAPITALIZING ON OPPORTUNITIES IN THE EUROPEAN NGS MARKET
      • 10.3.1.1. Launch of new and advanced products and services
      • 10.3.1.2. Strategic partnerships/agreements/collaborations to develop advanced techniques
    • 10.3.2. GERMANY, U.K., AND BELGIUM: MAJOR HUBS FOR SCIENTIFIC RESEARCH
    • 10.3.3. GROWING FUNDING AND INVESTMENTS FOR NGS IN EUROPE
  • 10.4. ASIA-PACIFIC
    • 10.4.1. GROWING FOCUS OF DOMESTIC AND MULTINATIONAL PLAYERS ON APAC MARKET
      • 10.4.1.1. Launch of advanced NGS products and services
      • 10.4.1.2. Partnerships/collaborations/agreements to co-develop advanced NGS products and services
    • 10.4.2. FAVORABLE GOVERNMENT FUNDING SCENARIO IN SEVERAL ASIA-PACIFIC COUNTRIES
    • 10.4.3. GROWTH IN THE NUMBER OF CONFERENCES/SEMINARS/TRAINING PROGRAMS IN THE ASIA-PACIFIC REGION
  • 10.5. REST OF THE WORLD (ROW)
    • 10.5.1. FOCUS OF KEY MARKET PLAYERS ON EXPANDING THEIR PRESENCE IN THE REST OF THE WORLD REGION
    • 10.5.2. GROWING NUMBER OF WORKSHOPS AND CONFERENCES
    • 10.5.3. IMPLEMENTATION OF FAVORABLE INITIATIVES BY PUBLIC AND PRIVATE ORGANIZATIONS

11. COMPETITIVE LANDSCAPE

  • 11.1. OVERVIEW
  • 11.2. MARKET SHARE ANALYSIS
  • 11.3. COMPETITIVE SITUATION AND TRENDS
    • 11.3.1. NEW PRODUCT LAUNCHES AND PRODUCT ENHANCEMENTS
    • 11.3.2. AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, AND CONTRACTS
    • 11.3.3. MERGERS AND ACQUISITIONS
    • 11.3.4. GEOGRAPHIC EXPANSIONS
    • 11.3.5. OTHER DEVELOPMENTS

12. COMPANY PROFILES

  • 12.1. INTRODUCTION
    • 12.1.1. GEOGRAPHIC BENCHMARKING
  • 12.2. ILLUMINA, INC.
  • 12.3. THERMO FISHER SCIENTIFIC, INC.
  • 12.4. PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
  • 12.5. BEIJING GENOMICS INSTITUTE
  • 12.6. QIAGEN N.V.
  • 12.7. 454 LIFE SCIENCES CORPORATION (ROCHE HOLDING AG)
  • 12.8. AGILENT TECHNOLOGIES, INC.
  • 12.9. EUROFINS SCIENTIFIC
  • 12.10. GATC BIOTECH AG
  • 12.11. MACROGEN INC.
  • 12.12. OXFORD NANOPORE TECHNOLOGIES, LTD.
  • 12.13. PERKINELMER, INC.

13. APPENDIX

  • 13.1. DISCUSSION GUIDE*
  • 13.2. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 13.3. AVAILABLE CUSTOMIZATIONS
  • 13.4. RELATED REPORTS

LIST OF TABLES

  • TABLE 1 NGS MARKET SIZE, BY PRODUCTS & SERVICES, 2014--2021 (USD MILLION)
  • TABLE 2 NGS MARKET SIZE, BY REGION, 2014--2021 (USD MILLION)
  • TABLE 3 PRE-SEQUENCING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2014--2021 (USD MILLION)
  • TABLE 4 PRE-SEQUENCING PRODUCTS & SERVICES MARKET SIZE, BY REGION, 2014--2021 (USD MILLION)
  • TABLE 5 DNA FRAGMENTATION, END REPAIR, A-TAILING, & SIZE SELECTION MARKET SIZE, BY REGION, 2014--2021 (USD MILLION)
  • TABLE 6 LIBRARY PREPARATION & TARGET ENRICHMENT MARKET SIZE, BY REGION, 2014--2021 (USD MILLION)
  • TABLE 7 QUALITY CONTROL MARKET SIZE, BY REGION, 2014--2021 (USD MILLION)
  • TABLE 8 NGS INSTRUMENTS, CONSUMABLES, AND SERVICES MARKET SIZE, 2014--2021 (USD MILLION)
  • TABLE 9 NGS PLATFORMS MARKET SIZE, BY REGION, 2014--2021 (USD MILLION)
  • TABLE 10 CONSUMABLES MARKET SIZE, BY REGION, 2014--2021 (USD MILLION)
  • TABLE 11 SERVICES FOR SYSTEMS MARKET SIZE, BY REGION, 2014--2021 (USD MILLION)
  • TABLE 12 ILLUMINA NGS PLATFORMS MARKET SIZE, BY PRODUCT, 2014--2021 (USD MILLION)
  • TABLE 13 ILLUMINA NGS PLATFORMS MARKET SIZE, BY REGION, 2014--2021 (USD MILLION)
  • TABLE 14 HISEQ SERIES PLATFORMS MARKET SIZE, BY REGION, 2014--2021 (USD MILLION)
  • TABLE 15 HISEQ X TEN & HISEQ X FIVE PLATFORMS MARKET SIZE, BY REGION, 2014--2021 (USD MILLION)
  • TABLE 16 MISEQ SERIES PLATFORMS MARKET SIZE, BY REGION, 2014--2021 (USD MILLION)
  • TABLE 17 NEXTSEQ 500 PLATFORMS MARKET SIZE, BY REGION, 2014--2021 (USD MILLION)
  • TABLE 18 THERMO FISHER SCIENTIFIC NGS PLATFORMS MARKET SIZE, BY PRODUCT, 2014--2021 (USD MILLION)
  • TABLE 19 THERMO FISHER SCIENTIFIC NGS PLATFORMS MARKET SIZE, BY REGION, 2014--2021 (USD MILLION)
  • TABLE 20 SOLID SERIES PLATFORMS MARKET SIZE, BY REGION, 2014--2021 (USD MILLION)
  • TABLE 21 ION PGM PLATFORMS MARKET SIZE, BY REGION, 2014--2021 (USD MILLION)
  • TABLE 22 ION PROTON PLATFORMS MARKET SIZE, BY REGION, 2014--2021 (USD MILLION)
  • TABLE 23 ION S5 & S5 XL PLATFORMS MARKET SIZE, BY REGION, 2014--2021 (USD MILLION)
  • TABLE 24 PACIFIC BIOSCIENCES NGS PLATFORMS MARKET SIZE, BY PRODUCT, 2014--2021 (USD MILLION)
  • TABLE 25 PACIFIC BIOSCIENCES NGS PLATFORMS MARKET SIZE, BY REGION, 2014--2021 (USD MILLION)
  • TABLE 26 PACBIO RS II PLATFORMS MARKET SIZE, BY REGION, 2014--2021 (USD MILLION)
  • TABLE 27 SEQUEL SYSTEM MARKET SIZE, BY REGION, 2014--2021 (USD MILLION)
  • TABLE 28 SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2014--2021 (USD MILLION)
  • TABLE 29 SEQUENCING SERVICES MARKET SIZE, BY REGION, 2014--2021 (USD MILLION)
  • TABLE 30 TARGETED SEQUENCING/GENE PANELS MARKET SIZE, BY REGION, 2014--2021 (USD MILLION)
  • TABLE 31 RNA-SEQ MARKET SIZE, BY REGION, 2014--2021 (USD MILLION)
  • TABLE 32 DE NOVO SEQUENCING MARKET SIZE, BY REGION, 2014--2021 (USD MILLION)
  • TABLE 33 EXOME SEQUENCING MARKET SIZE, BY REGION, 2014--2021 (USD MILLION)
  • TABLE 34 CHIP-SEQ MARKET SIZE, BY REGION, 2014--2021 (USD MILLION)
  • TABLE 35 WHOLE-GENOME SEQUENCING MARKET SIZE, BY REGION, 2014--2021 (USD MILLION)
  • TABLE 36 METHYL-SEQ MARKET SIZE, BY REGION, 2014--2021 (USD MILLION)
  • TABLE 37 OTHER APPLICATIONS MARKET SIZE, BY REGION, 2014--2021 (USD MILLION)
  • TABLE 38 NGS BIOINFORMATICS MARKET SIZE, BY PRODUCTS & SERVICES, 2014--2021 (USD MILLION)
  • TABLE 39 NGS BIOINFORMATICS MARKET SIZE, BY REGION, 2014--2021 (USD MILLION)
  • TABLE 40 DATA ANALYSIS SOFTWARE AND WORKBENCHES MARKET SIZE, BY REGION, 2014--2021 (USD MILLION)
  • TABLE 41 DATA ANALYSIS SERVICES MARKET SIZE, BY REGION, 2014--2021 (USD MILLION)
  • TABLE 42 NEXT-GENERATION SEQUENCING TECHNOLOGIES, BY COMPANY
  • TABLE 43 GLOBAL NEXT-GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2014--2021 (USD MILLION)
  • TABLE 44 SEQUENCING BY SYNTHESIS (SBS) MARKET SIZE, BY REGION, 2014--2021 (USD MILLION)
  • TABLE 45 ION SEMICONDUCTOR SEQUENCING MARKET SIZE, BY REGION, 2014--2021 (USD MILLION)
  • TABLE 46 SEQUENCING BY LIGATION MARKET SIZE, BY REGION, 2014--2021 (USD MILLION)
  • TABLE 47 PYROSEQUENCING MARKET SIZE, BY REGION, 2014--2021 (USD MILLION)
  • TABLE 48 SINGLE-MOLECULE REAL-TIME SEQUENCING (SMRT) MARKET SIZE, BY REGION, 2014--2021 (USD MILLION)
  • TABLE 49 GLOBAL NGS MARKET, BY APPLICATION, 2014--2021 (USD MILLION)
  • TABLE 50 DIAGNOSTICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 51 DRUG DISCOVERY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 52 BIOMARKER DISCOVERY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 53 PERSONALIZED MEDICINE MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 54 AGRICULTURE AND ANIMAL RESEARCH MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 55 OTHER APPLICATIONS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 56 GLOBAL NGS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 57 RESEARCH CENTERS, ACADEMIC/GOVERNMENT INSTITUTES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 58 HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 59 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 60 OTHER END USERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 61 NGS MARKET SIZE, BY REGION, 2014--2021 (USD MILLION)
  • TABLE 62 NORTH AMERICA: NGS MARKET SIZE, BY PRODUCTS & SERVICES, 2014--2021 (USD MILLION)
  • TABLE 63 NORTH AMERICA: NGS PRE-SEQUENCING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2014--2021 (USD MILLION)
  • TABLE 64 NORTH AMERICA: ILLUMINA NGS PLATFORMS MARKET SIZE, 2014--2021 (USD MILLION)
  • TABLE 65 NORTH AMERICA: THERMO FISHER SCIENTIFIC NGS PLATFORMS MARKET SIZE, 2014--2021 (USD MILLION)
  • TABLE 66 NORTH AMERICA: PACIFIC BIOSCIENCES NGS PLATFORMS MARKET SIZE, 2014--2021 (USD MILLION)
  • TABLE 67 NORTH AMERICA: SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2014--2021 (USD MILLION)
  • TABLE 68 NORTH AMERICA: NGS BIOINFORMATICS MARKET SIZE, BY PRODUCTS & SERVICES, 2014--2021 (USD MILLION)
  • TABLE 69 NORTH AMERICA: NGS MARKET SIZE, BY TECHNOLOGY, 2014--2021 (USD MILLION)
  • TABLE 70 NORTH AMERICA: NGS MARKET SIZE, BY APPLICATION, 2014--2021 (USD MILLION)
  • TABLE 71 NORTH AMERICA: NGS MARKET SIZE, BY END USER, 2014--2021 (USD MILLION)
  • TABLE 72 EUROPE: NGS MARKET SIZE, BY PRODUCTS & SERVICES, 2014--2021 (USD MILLION)
  • TABLE 73 EUROPE: NGS PRE-SEQUENCING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2014--2021 (USD MILLION)
  • TABLE 74 EUROPE: ILLUMINA NGS PLATFORMS MARKET SIZE, 2014--2021 (USD MILLION)
  • TABLE 75 EUROPE: THERMO FISHER SCIENTIFIC NGS PLATFORMS MARKET SIZE, 2014--2021 (USD MILLION)
  • TABLE 76 EUROPE: PACIFIC BIOSCIENCES NGS PLATFORMS MARKET SIZE, 2014--2021 (USD MILLION)
  • TABLE 77 EUROPE: SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2014--2021 (USD MILLION)
  • TABLE 78 EUROPE: NGS BIOINFORMATICS MARKET SIZE, BY PRODUCTS & SERVICES, 2014--2021 (USD MILLION)
  • TABLE 79 EUROPE: NGS MARKET SIZE, BY TECHNOLOGY, 2014--2021 (USD MILLION)
  • TABLE 80 EUROPE: NGS MARKET SIZE, BY APPLICATION, 2014--2021 (USD MILLION)
  • TABLE 81 EUROPE: NGS MARKET SIZE, BY END USER, 2014--2021 (USD MILLION)
  • TABLE 82 ASIA-PACIFIC: NGS MARKET SIZE, BY PRODUCTS & SERVICES, 2014--2021 (USD MILLION)
  • TABLE 83 ASIA-PACIFIC: NGS PRE-SEQUENCING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2014--2021 (USD MILLION)
  • TABLE 84 ASIA-PACIFIC: ILLUMINA NGS PLATFORMS MARKET SIZE, 2014--2021 (USD MILLION)
  • TABLE 85 ASIA-PACIFIC: THERMO FISHER SCIENTIFIC NGS PLATFORMS MARKET SIZE, 2014--2021 (USD MILLION)
  • TABLE 86 ASIA-PACIFIC: PACIFIC BIOSCIENCES NGS PLATFORMS MARKET SIZE, 2014--2021 (USD MILLION)
  • TABLE 87 ASIA-PACIFIC: SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2014--2021 (USD MILLION)
  • TABLE 88 ASIA-PACIFIC: NGS BIOINFORMATICS MARKET SIZE, BY PRODUCTS & SERVICES, 2014--2021 (USD MILLION)
  • TABLE 89 ASIA-PACIFIC: NGS MARKET SIZE, BY TECHNOLOGY, 2014--2021 (USD MILLION)
  • TABLE 90 ASIA-PACIFIC: NGS MARKET SIZE, BY APPLICATION, 2014--2021 (USD MILLION)
  • TABLE 91 ASIA-PACIFIC: NGS MARKET SIZE, BY END USER, 2014--2021 (USD MILLION)
  • TABLE 92 ROW: NGS MARKET SIZE, BY PRODUCTS & SERVICES, 2014--2021 (USD MILLION)
  • TABLE 93 ROW: NGS PRE-SEQUENCING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2014--2021 (USD MILLION)
  • TABLE 94 ROW: ILLUMINA NGS PLATFORMS MARKET SIZE, 2014--2021 (USD MILLION)
  • TABLE 95 ROW: THERMO FISHER SCIENTIFIC NGS PLATFORMS MARKET SIZE, 2014--2021 (USD MILLION)
  • TABLE 96 ROW: PACIFIC BIOSCIENCES NGS PLATFORMS MARKET SIZE, 2014--2021 (USD MILLION)
  • TABLE 97 ROW: SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2014--2021 (USD MILLION)
  • TABLE 98 ROW: NGS BIOINFORMATICS MARKET SIZE, BY PRODUCTS & SERVICES, 2014--2021 (USD MILLION)
  • TABLE 99 ROW: NGS MARKET SIZE, BY TECHNOLOGY, 2014--2021 (USD MILLION)
  • TABLE 100 ROW: NGS MARKET SIZE, BY APPLICATION, 2014--2021 (USD MILLION)
  • TABLE 101 ROW: NGS MARKET SIZE, BY END USER, 2014--2021 (USD MILLION)
  • TABLE 102 TOP 5 NEW PRODUCT LAUNCHES AND PRODUCT ENHANCEMENTS, 2013--2015
  • TABLE 103 TOP 5 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, AND CONTRACTS, 2013--2015
  • TABLE 104 TOP MERGERS AND ACQUISITIONS, 2013--2015
  • TABLE 105 TOP GEOGRAPHIC EXPANSIONS, 2013--2015
  • TABLE 106 TOP 5 OTHER DEVELOPMENTS, 2013--2015

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: BREAKDOWN OF SUPPLY-SIDE PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: NGS MARKET: BOTTOM-UP APPROACH
  • FIGURE 4: NGS MARKET: TOP-DOWN APPROACH
  • FIGURE 5: NGS MARKET: DATA TRIANGULATION
  • FIGURE 6: GLOBAL NGS MARKET, BY APPLICATION, 2016 (USD MILLION)
  • FIGURE 7: GLOBAL NGS PLATFORMS MARKET, 2016 VS. 2021
  • FIGURE 8: GLOBAL NGS MARKET, BY REGION, 2016 (USD MILLION)
  • FIGURE 9: ATTRACTIVE GROWTH OPPORTUNITIES IN THE NGS MARKET
  • FIGURE 10: PRE-SEQUENCING PRODUCTS & SERVICES SEGMENT IS EXPECTED TO GAIN MARKET SHARE IN 2021
  • FIGURE 11: METHYL-SEQ AND DE NOVO SEQUENCING IS EXPECTED TO GROW AT HIGHER CAGR FROM 2016 TO 2021
  • FIGURE 12: SEQUENCING BY SYNTHESIS TO COMMAND THE LARGEST SHARE OF THE NGS TECHNOLOGIES IN 2016
  • FIGURE 13: NGS MARKET, BY PRODUCTS & SERVICES
  • FIGURE 14: NGS MARKET, BY TECHNOLOGY
  • FIGURE 15: NGS MARKET, BY APPLICATION
  • FIGURE 16: NGS MARKET, BY END USER
  • FIGURE 17: NGS MARKET DYNAMICS
  • FIGURE 18: LIST OF SEQUENCING PLATFORMS LAUNCHED BY MARKET PLAYERS IN 2015-2016
  • FIGURE 19: NEW MARKET PLAYERS AND THEIR SEQUENCING PLATFORMS
  • FIGURE 20: TECHNOLOGICAL ADVANCEMENTS TO INCREASE ADOPTION OF NGS PLATFORMS
  • FIGURE 21: LACK OF SKILLED TECHNICIANS HINDERS THE NGS MARKET GROWTH
  • FIGURE 22: PERSONALIZED MEDICINE & BIOMARKER DISCOVERY OPEN AVENUES FOR THE GROWTH OF NGS MARKET
  • FIGURE 23: DATA STORAGE AND INTERPRETATION ARE MAJOR CONCERNS OF NGS MARKET
  • FIGURE 24: MAJOR ACQUISITIONS IN THE NGS MARKET
  • FIGURE 25: SMRT SEQUENCING IS EXPECTED TO GROW AT THE HIGHEST CAGR DURING 2016 TO 2021
  • FIGURE 26: DIAGNOSTICS SEGMENT TO HOLD LARGEST SHARE IN THE MARKET DURING 2016-2021
  • FIGURE 27: HOSPITALS & CLINICS END USER SEGMENT TO WITNESS HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 28: GLOBAL NGS MARKET OVERVIEW
  • FIGURE 29: NORTH AMERICAN NGS MARKET SNAPSHOT
  • FIGURE 30: EUROPEAN NGS MARKET SNAPSHOT
  • FIGURE 31: ASIA-PACIFIC NGS MARKET SNAPSHOT
  • FIGURE 32: ROW NGS MARKET SNAPSHOT
  • FIGURE 33: LEADING MARKET PLAYERS ADOPTED BOTH ORGANIC AND INORGANIC GROWTH STRATEGIES OVER THE LAST THREE YEARS (2013--2015)
  • FIGURE 34: GLOBAL NGS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2015
  • FIGURE 35: GEOGRAPHIC REVENUE MIX OF THE TOP FOUR MARKET PLAYERS* (2014)
  • FIGURE 36: ILLUMINA, INC.: COMPANY SNAPSHOT
  • FIGURE 37: THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
  • FIGURE 38: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: COMPANY SNAPSHOT
  • FIGURE 39: QIAGEN N.V.: COMPANY SNAPSHOT
  • FIGURE 40: ROCHE HOLDING AG: COMPANY SNAPSHOT
  • FIGURE 41: AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
  • FIGURE 42: EUROFINS SCIENTIFIC: COMPANY SNAPSHOT
  • FIGURE 43: MACROGEN INC.: COMPANY SNAPSHOT
  • FIGURE 44: PERKINELMER, INC.: COMPANY SNAPSHOT
Back to Top